Close
Nordic 9Nordic 9

Avidity Partners (investor - Private Equity)

United States aviditycapitalinc.com
See something wrong or missing? Let us know
Offices:San Diego
Average round investment:128.5M USD
Average number per year:2.0
Distribution: 2025 (2)
Portfolio companies: United Kingdom Artios PharmaUnited Kingdom OrganOx
Mostly invests in: United Kingdom United Kingdom (2) Manufacturing (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Avidity Partners

Name Criteria
United States Logos Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Intermediate Capital Group
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom AstraZeneca
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Qatar Qatar Investment Authority
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Patient Square Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Nordic Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Korelya Capital
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
United States Viking Global Investors
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Honeywell Ventures
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Catalio Capital Management
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top